Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA237691
Max Phase: Preclinical
Molecular Formula: C16H22N4O
Molecular Weight: 286.38
Molecule Type: Small molecule
Associated Items:
ID: ALA237691
Max Phase: Preclinical
Molecular Formula: C16H22N4O
Molecular Weight: 286.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOc1cc(NC2(CCCN)CC2)c2ncccc2n1
Standard InChI: InChI=1S/C16H22N4O/c1-2-21-14-11-13(15-12(19-14)5-3-10-18-15)20-16(7-8-16)6-4-9-17/h3,5,10-11H,2,4,6-9,17H2,1H3,(H,19,20)
Standard InChI Key: CJZGQSYESCZGPC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 286.38 | Molecular Weight (Monoisotopic): 286.1794 | AlogP: 2.71 | #Rotatable Bonds: 7 |
Polar Surface Area: 73.06 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.20 | CX LogP: 1.74 | CX LogD: -0.87 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.82 | Np Likeness Score: -0.63 |
1. Zhu S, Zhang Q, Gudise C, Meng L, Wei L, Smith E, Kong Y.. (2007) Synthesis and evaluation of naphthyridine compounds as antimalarial agents., 17 (22): [PMID:17900897] [10.1016/j.bmcl.2007.09.044] |
Source(1):